Please assess the completion status of the following clinical trial:

Trial Title: V260 Registration Study (V260-013)(COMPLETED)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* At first study vaccination, age 6 weeks through exactly 12 weeks~Exclusion Criteria:~* History of congenital abdominal disorders, intussusception, or abdominal surgery~* History of known prior rotavirus disease~* Ongoing chronic diarrhea or failure to thrive~* Clinical evidence of active gastrointestinal illness

- Gender: ALL
- Minimum Age: 6 Weeks
- Maximum Age: 12 Weeks
- Healthy Volunteers: t

Study Arms:
- 1 (Type: EXPERIMENTAL): RotaTeq
- 2 (Type: PLACEBO_COMPARATOR): Placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).